Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Календарь
Скринер
Новости
О нас

STXS - Stereotaxis, Inc. Последние новости | Finranks

Home

/

STXS

S

Stereotaxis, Inc. (STXS)

ASE – Цена в реальном времени. Валюта: USD

1.37

-0.09 (-6.16%)

Рынок открыт: Aug 12, 2026, 11:54 AM EDT

1.48

+0.02 (1.27%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript

Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript

Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript

Stereotaxis Q2 Earnings Call Highlights

Stereotaxis Q2 Earnings Call Highlights

Stereotaxis NYSEAMERICAN: STXS reported second-quarter 2026 revenue of $7.7 million, as growth in sales of its robotic catheter portfolio helped lift recurring revenue to a multiyear high despite lower system revenue and continued supply constraints.

Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates

Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates

Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.05 per share a year ago.

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

ST. LOUIS, Mo., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial results for the second quarter ended June 30, 2026.

Видео

No Data

There is no data to display

Пресс-релизы

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

ST. LOUIS, Mo., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial results for the second quarter ended June 30, 2026.